Literature DB >> 6825385

Atenolol interaction with aspirin, allopurinol, and ampicillin.

M Schäfer-Korting, W Kirch, T Axthelm, H Köhler, E Mutschler.   

Abstract

Atenolol kinetics were investigated in six healthy subjects after 100 mg orally, as monotherapy a 6-day treatment began 48 hr later. After a therapy-free interval of 4 wk, the same subjects received the same dose of atenolol with 1 gm ampicillin, 500 mg aspirin, and with 300 mg allopurinol. Allopurinol and aspirin did not substantially alter the kinetics of atenolol. After a single oral dose of 100 mg atenolol combined with 1 gm ampicillin, the bioavailability of atenolol was reduced to 36 +/- 5% compared to 60 +/- 8% after monotherapy. During long-term treatment with atenolol and ampicillin the bioavailability of atenolol fell to 24% (P less than 0.01). Mean peak plasma levels were lowered from 511 +/- 59 ng/ml on monotherapy to 344 +/- 33 ng/ml after the combination with ampicillin. The area under the plasma level-time curve, mean steady-state concentration, and urinary recovery were reduced, also. Twelve hours after 100 mg atenolol and 1 gm ampicillin, exercise tachycardia was significantly higher than after atenolol alone. During the 4-wk treatment in six hypertensive patients blood pressure levels of those on atenolol alone were not different from those on the combination therapy with ampicillin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825385     DOI: 10.1038/clpt.1983.34

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

2.  Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.

Authors:  E Naline; B Sarria; O Ertzbischoff; P Ozanne; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 3.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 4.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 5.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

6.  Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.

Authors:  A C Keech; R W Harper; P M Harrison; A Pitt; A J McLean
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Dose proportional absorption of 25-150 mg atenolol.

Authors:  M Wakelkamp; G Alván; G Paintaud; A Hedman
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Dose-dependence of atenolol-ampicillin interaction.

Authors:  A J McLean; A Tonkin; P McCarthy; P Harrison
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.

Authors:  W Kirch; H Spahn; N R Kitteringham; H J Hutt; E Mutschler; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.